NCT00569374

Safety and Tolerability of Modafinil for Methamphetamine Dependence

• Status: Completed
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 8 (actual)
• Sponsor: University of Arkansas · Academic / Other
• Sex: All
• Age: 18 Years – 65 Years
• Healthy volunteers: Accepted

Summary

This 7 week, open-label pilot clinical trial will examine the safety and tolerability of modafinil up to 400mg/day as a potential treatment to reduce methamphetamine use in methamphetamine-dependent volunteers.

Conditions

• Methamphetamine Dependence

Interventions

Type	Name	Description
DRUG	Modafinil	subjects attend clinic for the first week in order to receive meds; oral, 200mg/day doses for three days for initiation doses; increased to oral 400mg/day for the remainder of the trial (weeks 2-6); washout period during week 7

Timeline

• Start date: 2007-09-01
• Primary completion: 2008-09-01
• First posted: 2007-12-07
• Last updated: 2010-10-05
• Results posted: 2010-03-22

Locations

1 site across 1 country: United States